Sarcopenia: The gliogenic perspective

Mechanisms of Ageing and Development

Volumn 134, Issue 9, 2013, Pages 349-355

  Kwan, Ping ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Aging; Glia; Motor neuron; Muscle; Sarcopenia; Schwann cells

Indexed keywords

AGING; CENTRAL NERVOUS SYSTEM; CIRCULATION; GLIA; HUMAN; MOTONEURON; MOTOR UNIT; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; NERVE CELL; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PREVALENCE; PRIORITY JOURNAL; REVIEW; SARCOPENIA; SATELLITE CELL; SCHWANN CELL;

AGING; GLIA; MOTOR NEURON; MUSCLE; SARCOPENIA; SCHWANN CELLS;

AGING; ANIMALS; HUMANS; MOTOR NEURONS; MUSCLE CELLS; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEUROGLIA; NEURONS; PHENOTYPE; SARCOPENIA; SATELLITE CELLS, SKELETAL MUSCLE; SCHWANN CELLS; SYNAPSES;

EID: 84885847504     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.06.001     Document Type: Review

References (98)

1. Aagaard P., Suetta C., Caserotti P., Magnusson S.P., Kjaer M. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasure. Scandinavian Journal of Medicine & Science in Sports 2010, 20(1):49-64.
2. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience 2006, 7(1):41-53.
3. Abellan van Kan G. Epidemiology and consequences of sarcopenia. Journal of Nutrition Health and Aging 2009, 13(8):708-712.
4. Aberg N.D., Blomstrand F., Aberg M.A., Björklund U., Carlsson B., Carlsson-Skwirut C., Bang P., Rönnbäck L., Eriksson P.S. Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro. Journal of Neuroscience Research 2003, 74(1):12-22.
5. Akundi R.S., Zhi L., Büeler H. PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis. Neurobiology of Disease 2012, 45(1):469-478.
6. Alexei Verkhratsky, Arthur Butt Introduction to Glia. Glial Neurobiology 2007, 4-12. John Wiley and Sons, Inc., England.
7. Alexei V., Arthur B. General overview of signalling in the nervous system. Glial Neurobiology 2007, 15-17. John Wiley and Sons, Inc., England.
8. Alexei V., Arthur B. Morphology of Glial Cells. Glial Neurobiology 2007, 21-28. John Wiley and Sons, Inc., England.
9. Alexei V., Arthur B. Oligodendrocytes, Schwann Cells and Myelination. Glial Neurobiology 2007, 126-127. John Wiley and Sons, Inc., England.
10. Alway S.E., Degens H., Krishnamurthy G., Chaudhrai A. Denervation stimulates apoptosis but not Id2 expression in hindlimb muscles of aged rats. Journal of Gerontology Series A: Biological Sciences and Medical Sciences 2003, 58(8):687-697.
11. Amadio M., Scapagnini G., Laforenza U., Intrieri M., Romeo L., Govoni S., Pascale A. Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR. Current Pharmaceutical Design 2008, 14(26):2651-2658.
12. Argaw A.T., Asp L., Zhang J., Navrazhina K., Pham T., Mariani J.N., Mahase S., Dutta D.J., Seto J., Kramer E.G., Ferrara N., Sofroniew M.V., John G.R. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. Journal of Clinical Investigation 2012, 122(7):2454-2468.
13. Barres B.A. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008, 60(3):430-440.
14. Berger M.J., Doherty T.J. Sarcopenia: prevalence, mechanisms, and functional consequences. Interdisciplinary Topics in Gerontology 2010, 37:94-114.
15. Boumezbeur F., Mason G.F., de Graaf R.A., Behar K.L., Cline G.W., Shulman G.I., Rothman D.L., Petersen K.F. Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. Journal of Cerebral Blood Flow & Metabolism 2010, 30(1):211-221.
16. Braga M., Sinha Hikim A.P., Datta S., Ferrini M.G., Brown D., Kovacheva E.L., Gonzalez-Cadavid N.F., Sinha-Hikim I. Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis 2008, 13(6):822-832.
17. Brian M., Phillip G., Alan M. Skeletal Muscle: Form and Function. Human Kinetics 2006, 281. 2nd ed.
18. Bütikofer L., Zurlinden A., Bolliger M.F., Kunz B., Sonderegger P. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. FASEB Journal 2011, 25(12):4378-4393.
19. Burton L.A., McMurdo M.E., Struthers A.D. Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?. Clinical Endocrinology (Oxf). 2011, 75(6):725-729.
20. Calabresi P.A. Diagnosis and management of multiple sclerosis. American Family Physician 2004, 70(10):1935-1944.
21. Chai R.J., Vukovic J., Dunlop S., Grounds M.D., Shavlakadze T. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. PLoS ONE 2011, 6(12):e28090.
22. Chung W.S., Barres B.A. The role of glial cells in synapse elimination. Current Opinion in Neurobiology 2012, 22(3):438-445.
23. Chung P., Ng G. Taekwondo training improves the neuromotor excitability and reaction of large and small muscles. Physical Therapy in Sport 2012, 13(3):163-169.
24. Clark B.C., Manini T.M. Sarcopenia =/= dynapenia. Journal of Gerontology Series A: Biological Sciences and Medical Sciences 2008, 63(8):829-834.
25. Degens H. Age-related changes in the microcirculation of skeletal muscle. Advances in Experimental Medicine and Biology 1998, 454:343-348.
26. Dei R., Takeda A., Niwa H., Li M., Nakagomi Y., Watanabe M., Inagaki T., Washimi Y., Yasuda Y., Horie K., Miyata T., Sobue G. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathologica 2002, 104(2):113-122.
27. Derbré F., Gomez-Cabrera M.C., Nascimento A.L., Sanchis-Gomar F., Martinez-Bello V.E., Tresguerres J.A., Fuentes T., Gratas-Delamarche A., Monsalve M., Viña J. Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1α to exercise training. Age (Dordrecht, Netherlands) 2012, 34(3):669-679.
28. Deschenes M.R. Effects of aging on muscle fibre type and size. Sports Medicine 2004, 34(12):809-824.
29. Dirks A., Leeuwenburgh C. Apoptosis in skeletal muscle with aging. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2002, 282(2):R519-R527.
30. Dirks A.J., Leeuwenburgh C. The role of apoptosis in age-related skeletal muscle atrophy. Sports Medicine 2005, 35(6):473-483.
31. Farrall A.J., Wardlaw J.M. Blood-brain barrier: ageing and microvascular disease - systematic review and meta-analysis. Neurobiology of Aging 2009, 30(3):337-352.
32. Filosa J.A., Bonev A.D., Straub S.V., Meredith A.L., Wilkerson M.K., Aldrich R.W., Nelson M.T. Local potassium signaling couples neuronal activity to vasodilation in the brain. Nature Neuroscience 2006, 9(11):1397-1403.
33. Fitts R.H., Trappe S.W., Costill D.L., Gallagher P.M., Creer A.C., Colloton P.A., Peters J.R., Romatowski J.G., Bain J.L., Riley D.A. Prolonged space flight-induced alterations in the structure and function of human skeletal muscle fibres. Journal of Physiology 2010, 588(Pt 18):3567-3592.
34. Fong S.S., Tsang W.W., Ng G.Y. Taekwondo training improves sensory organization and balance control in children with developmental coordination disorder: a randomized controlled trial. Research in Developmental Disabilities 2012, 33(1):85-95.
35. Freiberger E., Sieber C., Pfeifer K. Physical activity, exercise, and sarcopenia - future challenges. Wiener Medizinische Wochenschrift 2011, 161(17-18):416-425.
36. Garatachea N., Lucía A. Genes and the ageing muscle: a review on genetic association studies. Age (Dordrecht, Netherlands) 2013, 35(1):207-233.
37. Giunta B., Fernandez F., Nikolic W.V., Obregon D., Rrapo E., Town T., Tan J. Inflammaging as a prodrome to Alzheimer's disease. Journal of Neuroinflammation 2008, 5:51.
38. Gomez A., Ferrer I. Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. Acta Neuropathologica 2010, 120(2):155-167.
39. Guillet C., Auguste P., Mayo W., Kreher P., Gascan H. Ciliary neurotrophic factor is a regulator of muscular strength in aging. Journal of Neuroscience 1999, 19(4):1257-1262.
40. Hall D.T., Ma J.F., Marco S.D., Gallouzi I.E. Inducible nitric oxisde synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging (Albany, NY) 2011, 3(8):702-715.
41. Hamrick M.W., Herberg S., Arounleut P., He H.Z., Shiver A., Qi R.Q., Zhou L., Isales C.M., Mi Q.S. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochemical and Biophysical Research Communications 2010, 400(3):379-383.
42. Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Research. Brain Research Reviews 2005, 48(3):457-476.
43. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiological Reviews 2006, 86(3):1009-1031.
44. Holden C. Neuroscience. Astrocytes secrete substance that kills motor neurons in ALS. Science 2007, 316(5823):353.
45. Howe M.L., Barres B.A. A novel role for microglia in minimizing excitotoxicity. BMC Biology 2012, 10:7.
46. Jackson M., Steers G., Leigh P.N., Morrison K.E. Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients. Journal of Neurology 1999, 246(12):1140-1144.
47. Jang Y.C., Van Remmen H. Age-associated alterations of the neuromuscular junction. Experimental Gerontology 2011, 46(2-3):193-198.
48. Janssen I. Evolution of sarcopenia research. Applied Physiology, Nutrition, and Metabolism 2010, 35(5):707-712.
49. Keller L.C., Cheng L., Locke C.J., Müller M., Fetter R.D., Davis G.W. Glial-derived prodegenerative signaling in the Drosophila neuromuscular system. Neuron 2011, 72(5):760-775.
50. Kettenmann H., Ransom B.R. Neuroglia 2005, Oxford University Press, New York. 2nd ed.
51. Kulakowski S.A., Parker S.D., Personius K.E. Reduced TrkB expression results in precocious age-like changes in neuromuscular structure, neurotransmission, and muscle function. Journal of Applied Physiology 2011, 111(3):844-852.
52. Kwan P. Sarcopenia, a neurogenic syndrome?. Journal of Aging Research 2013, 2013:791679. (Epub 2013 March 13). 10.1155/2013/791679.
53. Latimer C.S., Searcy J.L., Bridges M.T., Brewer L.D., Popović J., Blalock E.M., Landfield P.W., Thibault O., Porter N.M. Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice. PLoS ONE 2011, 6(10):e26812.
54. Lau E.M., Lynn H.S., Woo J.W., Kwok T.C., Melton L.J. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. Journal of Gerontology Series A: Biological Sciences and Medical Sciences 2005, 60(2):213-216.
55. Lee C.E., McArdle A., Griffiths R.D. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clinical Nutrition 2007, 26(5):524-534.
56. Lee J.S., Auyeung T.W., Kwok T., Lau E.M., Leung P.C., Woo J. Associated factors and health impact of arcopenia in older Chinese men and women: a cross-sectional study. Gerontology 2007, 53(6):404-410.
57. Li J., Ding Y.H., Rafols J.A., Lai Q., McAllister J.P., Ding Y. Increased astrocyte proliferation in rats after running exercise. Neuroscience Letters 2005, 386(3):160-164.
58. Li X., Khanna A., Li N., Wang E. Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging (Albany, NY) 2011, 3(10):985-1002.
59. Machado A., Herrera A.J., Venero J.L., Santiago M., De Pablos R.M., Villarán R.F., Espinosa-Oliva A.M., Argüelles S., Sarmiento M., Delgado-Cortés M.J., Mauriño R., Cano J. Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence. Parkinsons Disease 2011, 2011:393769. (Epub 2011 April 13).
60. Mantilla C.B., Sieck G.C. Key aspects of phrenic motoneuron and diaphragm muscle development during the perinatal period. Journal of Applied Physiology 2008, 104(6):1818-1827.
61. Martin L.J. Mitochondrial pathobiology in ALS. Journal of Bioenergetics and Biomembranes 2011, 43(6):569-579.
62. Mayer F., Scharhag-Rosenberger F., Carlsohn A., Cassel M., Müller S., Scharhag J. The intensity and effects of strength training in the elderly. Deutsches Ärzteblatt International 2011, 108(21):359-364.
63. McEachern J.C., Shaw C.A. The plasticity-pathology continuum: defining a role for the LTP phenomenon. Journal of Neuroscience Research 1999, 58(1):42-61.
64. Muntané G., Dalfó E., Martínez A., Rey M.J., Avila J., Pérez M., Portero M., Pamplona R., Ayala V., Ferrer I. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. Journal of Neurochemistry 2006, 99(1):177-185.
65. Muscaritoli M., Anker S.D., Argilés J., Aversa Z., Bauer J.M., Biolo G., Boirie Y., Bosaeus I., Cederholm T., Costelli P., Fearon K.C., Laviano A., Maggio M., Rossi Fanelli F., Schneider S.M., Schols A., Sieber C.C. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clinical Nutrition 2010, 29(2):154-159.
66. Nguyen D., Alavi M.V., Kim K.Y., Kang T., Scott R.T., Noh Y.H., Lindsey J.D., Wissinger B., Ellisman M.H., Weinreb R.N., Perkins G.A., Ju W.K. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Disease 2011, 2:e240. 10.1038/cddis.2011.117.
67. Noren Hooten N., Abdelmohsen K., Gorospe M., Ejiogu N., Zonderman A.B., Evans M.K. microRNA expression patterns reveal differential expression of target genes with age. PLoS ONE 2010, 5(5):e10724.
68. Ooishi Y., Kawato S., Hojo Y., Hatanaka Y., Higo S., Murakami G., Komatsuzaki Y., Ogiue-Ikeda M., Kimoto T., Mukai H. Modulation of synaptic plasticity in the hippocampus by hippocampus-derived estrogen and androgen. Journal of Steroid Biochemistry and Molecular Biology 2012, 131(1-2):37-51.
69. Ozdemir D., Baykara B., Aksu I., Kiray M., Sisman A.R., Cetin F., Dayi A., Gurpinar T., Uysal N., Arda M.N. Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats. Neuroscience Letters 2012, 507(1):84-89.
70. Paasche G., Gärtner U., Germer A., Grosche J., Reichenbach A. Mitochondria of retinal Müller (glial) cells: the effects of aging and of application of free radical scavengers. Ophthalmic Research 2000, 32(5):229-236.
71. Papadopoulos M.C., Koumenis I.L., Yuan T.Y., Giffard R.G. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience 1998, 82(3):915-925.
72. Power G.A., Dalton B.H., Behm D.G., Doherty T.J., Vandervoort A.A., Rice C.L. Motor unit survival in lifelong runners is muscle dependent. Medicine and Science in Sports and Exercise 2012, 44(7):1235-1242.
73. Rao S.D., Weiss J.H. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends in Neurosciences 2004, 27(1):17-23.
74. Rosenberg I.H. Sarcopenia: origins and clinical relevance. Journal of Nutrition 1997, 127(5 Suppl.):990S-991S.
75. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutrition Reviews 2007, 65(12 Pt 2):S208-S212.
76. Saini A., Faulkner S., Al-Shanti N., Stewart C. Powerful signals for weak muscles. Ageing Research Reviews 2009, 8(4):251-267.
77. Sale D.G. Neural adaptation to resistance training. Medicine and Science in Sports and Exercise 1988, 20(5 Suppl.):S135-S145.
78. Sanchis-Gomar F., Gómez-Cabrera M.C., Viña J. The loss of muscle mass and sarcopenia: nonhormonal intervention. Experimental Gerontology 2011, 46(12):967-969.
79. Sanders E.J., Lin W.Y., Parker E., Harvey S. Growth hormone promotes the survival of retinal cells in vivo. General and Comparative Endocrinology 2011, 172(1):140-150.
80. Schiaffino S., Murgia M., Serrano A.L., Calabria E., Pallafacchina G. How is muscle phenotype controlled by nerve activity?. Italian Journal of Neurological Science 1999, 20(6):409-412.
81. Schubert P., Ogata T., Marchini C., Ferroni S. Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target?. Mechanisms of Ageing and Development 2001, 123(1):47-57.
82. Seifert G., Schilling K., Steinhäuser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nature Reviews 2006, 7:194-206.
83. Sierra A., Gottfried-Blackmore A.C., McEwen B.S., Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 2007, 55(4):412-424.
84. Siu P.M., Pistilli E.E., Alway S.E. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. Journal of Applied Physiology 2008, 105(6):1695-1705.
85. Sriram S., Subramanian S., Sathiakumar D., Venkatesh R., Salerno M.S., McFarlane C.D., Kambadur R., Sharma M. Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB. Aging Cell 2011, 10(6):931-948.
86. Steele M.L., Robinson S.R. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiology of Aging 2012, 33(2). 423.e1-e13.
87. Takano T., Tian G.F., Peng W., Lou N., Libionka W., Han X., Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nature Neuroscience 2006, 9(2):260-267.
88. Tan L.J., Liu S.L., Lei S.F., Papasian C.J., Deng H.W. Molecular genetic studies of gene identification for sarcopenia. Human Genetics 2012, 131(1):1-31.
89. Teismann P., Tieu K., Cohen O., Choi D.K., Wu D.C., Marks D., Vila M., Jackson-Lewis V., Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Movement Disorders 2003, 18(2):121-129.
90. Tsai L.K., Chen Y.C., Cheng W.C., Ting C.H., Dodge J.C., Hwu W.L., Cheng S.H., Passini M.A. IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice. Neurobiology of Disease 2012, 45(1):272-279.
91. Visser M., Schaap L.A. Consequences of sarcopenia. Clinics in Geriatric Medicine 2011, 27(3):387-399.
92. Volkert D. The role of nutrition in the prevention of sarcopenia. Wiener Medizinische Wochenschrift 2011, 161(17-18):409-415.
93. Wang F.C., de Pasqua V., Delwaide P.J. Age-related changes in fastest and slowest conducting axons of thenar motor units. Muscle Nerve 1999, 22(8):1022-1029.
94. Whishaw I.Q., Bryan K. The Behavior of the Laboratory Rat: A Handbook with Tests 2005, 327. Oxford University Press.
95. Wyse B., Sernia C. Growth hormone regulates AT-1a angiotensin receptors in astrocytes. Endocrinology 1997, 138(10):4176-4180.
96. Yudkoff M., Daikhin Y., Grunstein L., Nissim I., Stern J., Pleasure D., Nissim I. Astrocyte leucine metabolism: significance of branched-chain amino acid transamination. Journal of Neurochemistry 1996, 66(1):378-385.
97. Yudkoff M. Brain metabolism of branched-chain amino acids. Glia 1997, 21(1):92-98.
98. Zhang P., Chen X., Fan M. Signaling mechanisms involved in disuse muscle atrophy. Medical Hypotheses 2007, 69(2):310-321.